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Menière’s disease and vestibular migraine (VM) are the most common causes of spon-
taneous recurrent vertigo. The current diagnostic criteria for the two disorders are mainly
based on patients’ symptoms, and no biological marker is available. When applying these
criteria, an overlap of the two disorders is occasionally observed in clinical practice. There-
fore, the present prospective multicenter study aimed to identify accompanying symp-
toms that may help to differentiate between MD, VM, and probable vestibular migraine
(pVM).Two hundred and sixty-eight patients were included in the study (MD: n=119, VM:
n=84, pVM: n=65). Patients with MD suffered mainly from accompanying auditory symp-
toms (tinnitus, fullness of ear, and hearing loss), while accompanying migraine symptoms
(migraine-type headache, photo-/phonophobia, visual aura), anxiety, and palpitations were
more common during attacks of VM. However, it has to be noted that a subset of MD
patients also experienced (migraine-type) headache during the attacks. On the other hand,
someVM/pVM patients reported accompanying auditory symptoms.The female/male ratio
was statistically higher in VM/pVM as compared to MD, while the age of onset was signifi-
cantly lower in the former two.The frequency of migraine-type headache was significantly
higher in VM as compared to both pVM and MD. Accompanying headache of any type
was observed in declining order in VM, pVM, and MD. In conclusion, the present study
confirms a considerable overlap of symptoms in MD, VM, and pVM. In particular, we could
not identify any highly specific symptom for one of the three entities. It is rather the combi-
nation of symptoms that should guide diagnostic reasoning. The identification of common
symptom patterns in VM and MD may help to refine future diagnostic criteria for the two
disorders.
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INTRODUCTION
The most common causes of spontaneous recurrent vertigo are
vestibular migraine (VM) and Menière’s disease (MD) (1). In the
absence of a diagnostic gold standard and confirmatory tests, the
diagnosis is largely based on the history, including the duration
of vestibular symptoms, accompanying cochlear and neurologic
symptoms and exclusion of other causes (2, 3). Diagnostic criteria
for VM have recently been published by the Bárány Society and the
International Headache Society (2, 4). A previous version of these
operational criteria has shown high reliability and validity (5).
The criteria for VM require that in a person with a past or ongo-
ing history of migraine, at least 50% of the vestibular episodes are
accompanied by migrainous symptoms such as headache, visual
aura, and/or photo- and phonophobia (2, 4). For probable vestibu-
lar migraine (pVM), either a history of migraine or migraine
symptoms during the attack are sufficient (2, 4). The criteria
for MD by the American Academy of Otolaryngology-Head and
Neck Surgery (AAO-HNS) require accompanying auditory symp-
toms and audiometrically documented hearing loss on at least one
occasion (6). Vestibular testing results are neither required for a
diagnosis of VM nor for MD.
Despite these operational criteria, the interface between vertigo
and headache is complex (7) and the discrimination between MD
and VM remains a challenge, in particular in the early course of
the disorders (8–11). Of note, patients with MD have a dispropor-
tionally high prevalence of headache, including migraine (12–14).
Furthermore, cochlear symptoms are not exclusive to MD but may
similarly occur during attacks of VM (15, 16). Only patients who
have two different types of attacks, one fulfilling the criteria for VM
and the other for MD, should be diagnosed with both disorders (4).
The development of internationally accepted diagnostic crite-
ria is quite recent in the vestibular field (2, 4). At an early stage,

























































Lopez-Escamez et al. Overlapping phenotype in episodic vestibular syndrome
the development of disease classifications and of diagnostic crite-
ria is mainly based on expert opinions rather than on robust data
(17). Once established, these criteria can be widely applied and
their validity can be tested. One way of validation is to assess the
stability of the diagnosis over time (18).
The aim of this study is to systematically assess accompanying
symptoms of vestibular attacks in patients fulfilling current criteria
for VM, pVM, and MD to enhance the phenotypic description of
these episodic vestibular disorders. As a result, the features, which
discriminate best or least between the two, should become clearer
and help to guide the clinician in his history taking and diagnostic
decisions. The data could also contribute to the discussion if VM




Four hundred and twenty-three patients presenting with an
episodic vestibular syndrome were recruited between August 2013
and March 2014 in a prospective multicenter study performed in
Italy, Luxembourg, Germany and Spain in six clinical centers. All
patients were interviewed by experienced neuro-otologists (three
neurologists and three otolaryngologists) with at least 12 years of
clinical practice. The centers were tertiary referral outpatient clin-
ics or vertigo clinics in general hospitals. For the present analysis,
we selected a total of 268 patients fulfilling either the diagnostic
criteria for MD according to the American Academy of Head and
Neck Surgery (6) or the diagnostic criteria for VM or pVM (2, 4) to
characterize the clinical symptoms during the episodes of vertigo.
Patients fulfilling the criteria for both MD and VM (either VM or
pVM) were excluded from the study.
This study was approved by the local ethics committees of all
participating centers. All patients gave written informed consent
before entering the study.
METHODS
All patients were examined by clinical testing for spontaneous and
positional nystagmus, smooth pursuit, saccades, and head impulse
test. A pure tone audiogram was performed in all patients to
determine bone and air conduction hearing thresholds. Additional
tests to exclude other differential diagnoses were performed at the
discretion of each clinician to establish the diagnosis.
A structured questionnaire was designed to record the symp-
toms according to the Bárány Vestibular Symptoms Grid to
characterize the vestibular phenotype (19). The questionnaire
was designed to collect all vestibular symptoms reported by
patients (vertigo, dizziness, vestibulo-visual symptoms, pos-
tural symptoms), the frequency, and duration of the attacks
and the intensity of the symptoms. The questionnaire also
included basic demographic data (age and gender), patient’s
age at onset of vestibular symptoms, and a set of questions to
determine the accompanying symptoms occurring during the
attacks, i.e., vision-related symptoms (photophonia, visual aura,
diplopia), hearing-related symptoms (phonophobia, tinnitus, full-
ness of ear, hearing loss), vegetative symptoms (nausea, vomit-
ing, palpitations, choking), emotional symptoms (anxiety), and
headache (Table 1). Patients were able to choose if accompanying
symptoms occurred never, sometimes (<50% of attacks) or mostly
(≥50% of attacks).
To characterize the type of headache during the attack, the
interview included specific questions concerning localization (uni-
lateral?), quality (pulsating ?), intensity of headache (moderate to
severe?), and aggravation of headache by activity. Each question
could be answered as never, sometimes or mostly and scored as 0,
1, or 2, respectively. A composite migraine risk score (MRS) was
calculated for the patients suffering from headache as the sum of
these four items. Thus, MRS ranged from 0 to a maximum of 8.
A statistical analysis was performed using SAS 9.3 software.
Absolute and relative frequencies were calculated for each
accompanying symptom occurring during the attacks. The
observed frequency of each symptom was compared between
Table 1 | Summary of the structured questionnaire designed to
characterize symptoms in the vestibular episodic syndrome.
Questions















Attack duration Core event
Duration of recovery time
Distinctive exacerbation? Duration
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aClusters refer to the temporal aggregation in episodes of vestibular symptoms.
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patients with MD,VM, and pVM using Chi2 test with Yates’ correc-
tion or Fisher’s exact test. Student’s t tests were used to compare
the age of onset of pVM, VM, and MD. A p-value <0.05 was
considered statistically significant.
RESULTS
One hundred and nineteen patients with MD were included in
the study. The age at onset of vertigo was 48± 13 years and the
female/male ratio was 1.2. The accompanying symptoms reported
during the episodes of vertigo are shown in Table 2. The most com-
mon symptoms in patients with MD (total frequency) were nausea
(94%), vomiting (84%), and tinnitus (83%). Accompanying hear-
ing loss was reported in 77% of cases, headache was found in 41%
of patients with MD, and migraine-type headache was observed
in 8.4% of MD patients during the attack (Figure 1). Although we
did not study the relationship between perceived hearing loss and
hearing threshold in the audiogram systematically, we noted that
some patients with MD, who did not report hearing loss during
attacks, had a profound chronic sensorineural hearing loss on the
audiogram (>70 dB normal hearing level).
Another 84 patients had VM and 65 had PVM. The age at
onset of the disease was 43± 14 years for VM and 42± 13 years
for pVM, being both significantly lower when compared with MD
(t test,p= 0.007 for VM and p= 0.005 for pVM). The female/male
ratio was 7.4 and 4.4, respectively. The most frequent accompa-
nying symptom in both groups was headache (95% in VM and
66% in pVM), followed by nausea, anxiety, phonophobia, and
photophobia (Table 2). Comparing the frequency of symptoms
between VM and pVM, we found that the following symptoms
were more common in patients with VM: photophobia, vomiting,
and headache (all p< 0.001) and also phonophobia (p= 0.002).
Moreover, headache with migrainous features was observed more
frequently in VM than in pVM patients (unilateral, p< 0.001;
moderate or severe intensity,p< 0.001; pulsating quality,p= 0.03;
worse on effort, p= 0.001).
Comparing the frequency of symptoms between MD and VM,
we found that tinnitus, aural fullness, and hearing loss were less
common in patients with VM than MD (all, p< 0.001). More-
over, vomiting was also most frequently observed in patients with
MD than VM (p= 0.002). Conversely, photo- and phonophobia
(p< 0.001), visual aura (p< 0.001), palpitations (p= 0.008), and
anxiety (p= 0.024) were reported more often by patients with VM
than MD.
The percentage of patients with VM, pVM, and MD report-
ing headache during vestibular attacks was 95.2, 66.1, and 41.2%
for, respectively. Among patients reporting headache, the headache
compatible with migraine (headache with at least two of the four
features mentioned above during most of the episodes) was found
in 72.5, 25.6, and 20.4% for VM, pVM, and MD. The frequency
of headache (any type) and migraine-type headache was signifi-
cantly higher in patients with VM compared to patients with pVM
and MD (Figure 1; p< 0.001 each). The MRS was also signifi-
cantly higher in patients with VM compared to either pVM or MD
(p< 0.001 each; MRS was 5.6± 1.8 in VM, 3.7± 1.8 in pVM, and
3.0± 2.1 in MD), but interestingly no significant difference was
observed between patients with MD and pVM. Of note, no patient
in our series with a diagnosis of MD or pVM had a MRS= 8, and
only patients with a diagnosis of VM reached the maximum score.
Table 2 | Accompanying symptoms reported by patients with definite and probable VM during the attack.
Symptoms Relative frequency (%)
MD VM Probable VM
Mostly Sometimes Mostly Sometimes Mostly Sometimes
Nausea 80.7 13.4 76.2 17.9 43.1 43.1
Tinnitus 68.1 15.1 20.2 26.2 9.2 21.5
Hearing loss 61.3 16.0 10.7 15.5 9.2 6.2
Fullness of ear 61.3 19.3 14.3 20.2 7.7 20.0
Phonophobia 31.1 31.1 60.7 19.1 32.3 29.2
Photophobia 21.0 20.2 57.1 22.6 26.1 33.9
Visual aura 0.8 10.1 13.1 19.0 6.2 9.2
Anxiety 34.4 43.7 50.0 40.5 44.6 35.4
Vomiting 46.2 37.8 23.8 45.2 7.7 20.0
Palpitations 3.4 31.1 14.3 35.7 13.9 41.5
Choking 5.0 6.7 7.1 15.5 7.7 10.8
Diplopia 0.0 7.6 2.4 9.5 1.5 6.2
Headache 41.2 95.2 66.1
Migraine-type headache 8.4 69.1 16.9
Headache features
Worse on effort 20.4 40.8 62.5 23.8 27.9 51.2
Moderate of severe 20.4 40.8 57.5 35.0 18.6 53.5
Unilateral 10.2 40.8 52.5 27.5 14.0 48.8
Pulsating quality 18.4 38.8 45.0 35.0 20.9 48.8
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FIGURE 1 | Relative frequency of headache and migraine-type
headache during the episode of vestibular symptoms among patients
with Menière’s disease (MD), vestibular migraine (VM), and probable
VM (pVM).
DISCUSSION
This study demonstrates, quite expectedly, that patients with VM
and pVM have mostly migraine symptoms during their attacks
while patients with MD have mostly auditory symptoms. On
the other hand, there is a considerable overlap of accompany-
ing symptoms. Our findings suggest that both VM and pVM are
more commonly found in women (four to eight times), which
does not apply to MD. Migraine is three times more common in
women and it typically occurs in young patients with a peak preva-
lence in the fourth decade, regardless of the presence of vestibular
symptoms (20).
Moreover, the mean age of onset in our cohorts is differ-
ent between VM/pVM and MD with VM/pVM manifesting ear-
lier. Of note, a relevant subset of patients with MD, around
40%, presents with headaches during their vertigo attacks and,
interestingly, more than 8.4% of patients with MD describe
headaches compatible with migraine (i.e., 20% of MD patients
suffering from headache describe headaches compatible with
migraine). In this study, we excluded patients fulfilling the cri-
teria for both MD and VM, so we are probably underestimat-
ing the prevalence of headache, including migraine, and hear-
ing loss in our series compared to an unselected patient pop-
ulation presenting with episodic vertigo. Neither headache nor
migraine is considered as an exclusion criterion in MD in the
current definition of the AAO-HNS (6), nor do the instruc-
tions warn the clinician to carefully consider VM as a dif-
ferential diagnosis. In fact, the presence of headache, includ-
ing migraine, during the vertigo attack does not rule out the
diagnosis of MD (7, 12). Phonophobia and photophobia were
also reported by some patients with MD, and these concur-
rent symptoms can make the differentiation between MD and
VM/pVM confusing as these symptoms are part of the VM/pVM
criteria (2, 4).
A second finding of our study is that a subset of patients with
VM also experience auditory symptoms, especially tinnitus, dur-
ing the attack. The definition of VM requires that at least 50% of
the attacks are accompanied by migraine features (2, 4), but audi-
tory symptoms are not considered except phonophobia. This also
suggests an overlapping phenotype between patients with VM and
MD. However, our results indicate that lack of certain auditory
symptoms, especially hearing loss, are suggestive for a diagnosis of
either VM or pVM. Phonophobia is similarly frequent in MD and
pVM, but more frequent in VM.
A third point to mention from our data is that anxiety and
palpitations and nausea are more common symptoms during the
attack in patients with VM compared with MD. Vomiting occurs
in most patients with MD and it has a lower frequency. In VM,
but it is only found in one out of four patients with pVM. Vom-
iting may be part of migraine as such, as well as a consequence
of vertigo, vomiting in association with auditory symptoms may
help to discriminate between MD and VM.
A subset of patients with MD, who showed hearing loss in the
audiogram after the episode, did not perceive hearing loss dur-
ing the attack. This observation applies especially to patients with
a constant severe sensorineural hearing loss on the affected ear,
which temporarily got worse during the vertigo attack. This shows
that hearing loss can be missed by history taking and underlines
the importance of audiometric testing in all patients with episodic
vertigo to prevent a delay in the diagnosis of MD.
The MRS is a composite score aiming to estimate the proba-
bility that a headache has a migrainous character based on four
questions. However, this score does not consider the number of
headache attacks and it cannot replace the IHS criteria for the diag-
nosis of migraine (4). Our data demonstrate that the MRS can be
useful to differentiate MD from VM, since VM patients reached a
higher score than patients with MD or pVM. This is likely to be, at
least in part, a direct result of the diagnostic criteria. Nevertheless,
a high MRS score may point to VM, in particular when hearing
loss is absent since only patients with VM reached the maximum
score (MRS= 8). Although this finding should be validated in a
larger cohort of patients with MD, VM, and pVM, the application
of the MRS in clinical practice to improve the diagnostic accuracy
of VM seems promising.
Our study has several limitations. Anxiety and depression are
comorbid conditions with MD and VM, and we did not use a
specific instrument for their diagnosis since this study was not
designed to estimate the comorbidities of these psychiatric condi-
tions. Psychiatric comorbidity has recently been reported in half of
patients with vertigo/dizziness using a structured clinical interview
for major mental disorders (21). A second limitation is the fact that
the family history of migraine or MD was not considered for the
diagnosis and both VM and MD have a strong trend for famil-
ial clustering (22). Since there is a frequent association between
episodic vertigo, migraine, and MD in close relatives, including
identical twins, it is possible that MD and VM can share a com-
mon genetic link with variable expression of hearing loss, episodic
vertigo, visual aura, and migraine in the same families (23). Finally,
for the diagnosis of definite VM, the diagnosis of migraine was
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made according to IHS criteria, but regarding the quality of the
headache accompanying the vertigo episodes, our questionnaire
only allowed to establish how many migraine features were present,
but not if it fulfilled a migraine diagnosis according to IHS criteria.
All of the accompanying symptoms studied here (except visual
aura) may occur in these three disorders but with different fre-
quencies. In summary, subjective hearing loss, tinnitus, and full-
ness of the ear are much more common in MD. We did not
assess severity of symptoms, which may further aid the differ-
entiation of VM and MD. According to our clinical experience,
we would expect that hearing loss or tinnitus during attacks of
MD were more pronounced than during attacks of VM, which
needs to be investigated in further studies. Visual aura, if present,
points toward VM. Although both, photophobia and phonopho-
bia, are more frequent in VM than in MD, they do not seem to
have strong discriminating power between pVM and MD, while
headache performs slightly better and favors a diagnosis of VM.
It is somewhat discomforting that some essential criteria of the
VM definition – the accompanying migraine symptoms – are rel-
atively weak discriminators against MD. Instead, it is the absence
or presence of hearing symptoms (except phonophobia) and the
absence/presence of hearing loss on audiometry, which really
count. It is likely, although unproven, that migraine symptoms
during the attack are more useful for distinction of VM from other
causes of recurrent vertigo, such as benign paroxysmal positional
vertigo, vertebrobasilar TIA, or vestibular paroxysmia.
In conclusion, the present study shows that differences in
accompanying symptoms during attacks in MD, VM, and pVM
are present in a group comparison, but the considerable overlap
of symptoms renders the differential diagnosis in the individ-
ual patient challenging. Future studies may address the question
whether VM and MD just overlap with regard to clinical phenom-
enology or if they represent variant phenotypes of a broad clinical
spectrum disorder.
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